Conventionally, culture medium is supplemented with fetal bovine serum (FBS): such serum presents poten tial risks of foreign protein contamination and transmission of viral or prion-related disease if used in culture of cells intended for human reimplantation. As it has been suggested that a composite of cultured human cancellous bone-derived cells and a bone graft substitute may present a solution to the well-recognized complications and limited availability associated with harvest of fresh bone graft, this study aimed to com pare the proliferative response of human cancellous bone-derived cells supplemented with FBS or autologous human serum (AHS) to determine whether AHS is a practical alternative. Explant cultures were established using greater trochanter trabecular bone from 10 consenting patients (aged 57-84) undergoing total hip arthroplasty. At the same time, serum was harvested. The cells were characterized by alkaline phosphatase expression and by in vino mineralization in enhanced medium. At confluence, cells were aliquoted into multiwell plates and grown for 9 days in medium supplemented with 5%, 10%, 15%, or 20% AHS or 10% FBS. Proliferative response was determined by a crystal violet dye binding assay. There was no significant difference between proliferation in 5% AHS and 10% FBS. However, 10%, 15%, and 20% AHS all produced significantly greater proliferation than 10% FBS. The proliferative response was dose related. FBS is said to be rich in growth and attachment factors, which is why it is widely used in tissue culture. These results suggest that species specificity, even when using adult serum, outweighs these advantages. It should there fore be considered as a prerequisite for any program involving reimplantation of cultured human cells. Clinical trials of cultured human cancellous bone-derived cells have now begun.
INTRODUCTION
The addition of serum has been used in bone cell cultures, as it has been regarded as necessary to permit multiplication and expression of a differentiated pheno type in an osteoblast cell line (27) . Serum contains growth factors, hormones that modulate growth and cell function, attachment and spreading factors, transport proteins for hormones, trace elements, and other nutri ents (14) . To date, little attention has been focused on the optimal regimen to maximize bone-derived cell pro liferation in vitro.
Animal osteoblasts have been cultured in media sup plemented with species-specific and nonspecific sera at a variety of concentrations. For example, Williams et al. (26) grew adult rat bone cells in media supplemented with fetal bovine serum (FBS), horse serum, or a combi nation of both. They reported that all sera supported growth and differentiation in culture, at least for early generations of cells, but did not elaborate on the optimal concentration. They did, however, comment that "10% FBS was found to be sufficient for subsequent passage" after culture was established. Other reports have de scribed rat bone-derived cell culture in media supple mented with 10% FBS (3) and with 15% FBS (2) . Nijweide et al. (16) reported culture of chick osteoblast-like cells in medium supplemented with 10% cock serum and found that these cells formed bone in vitro. Lower serum requirements were reported for mouse osteoblastlike cells, which were cultured and remained differenti ated in medium supplemented with as low as 3% FBS (28) . tured in DMEM supplemented with 10%, 15%, and 20% FBS and recommended 15% as the optimal concentra tion throughout growth and mineralization.
Human osteoblastic cells have been grown in a-minimal essential nedium (a-MEM), MCDB medium, and Fitton-Jackson modification of Biggers Gwatkin Judah Medium (BGJb) supplemented with 10% FBS and in a-MEM without serum (12) . Growth was maximal in oc-MEM with 10% FBS. In this medium it was noted that 50 mM ascorbic acid was also necessary for cell growth, and although ascorbic acid has been recommended for in vitro mineralization (8) , it has not been widely used simply to promote cell proliferation.
FBS provides a rich source of growth factors and nu trients, a number of which are platelet derived. It has been found to be highly stimulatory for cells of mesen chymal origin and is easy to obtain (19) . Growth of hu man bone-derived cells in FBS-supplemented medium results in greater cellular proliferation than that seen with use of platelet-poor plasma (PPP) (19) . These au thors have shown that addition of the platelet-derived growth factors, TGF-P, PDGF, and FGF to PPP results in equivalent cell proliferation to that obtained with FBS. Additionally, supplementation of human bonederived cell culture with human platelet concentrate re sulted in enhanced cell proliferation when compared to 10% serum supplementation (23) . Wergadal and Baylink (24) compared the growth of cultured human bone-de rived cells with varying concentrations of FBS and with FBS-free medium. They reported that cells did not pro liferate in the absence of FBS and advised that "the opti mal supplementation was 10% or greater."
Freshly obtained autologous serum is said to be pref erable for bone cell culture (17) , so it is perhaps surpris ing that its use in human cells has not been more widely investigated. Cells isolated from human trabecular bone fragments have shown greater proliferation in medium supplemented with 10% autologous human serum than with FBS, but no attempt was made to assess the pheno type of the cells (21) . In previous work by this group, cancellous bone-derived cells, which were extensively phenotyped, showed enhanced proliferation in both pooled and autologous human serum at 10% (10) .
It has been suggested that cultured osteoblasts could be used for reconstruction of skeletal defects in patients 
Harvesting Autologous Serum
The harvested blood was kept at room temperature for 4 h and then refrigerated overnight at 4°C, to allow for platelet degranulation and release of growth factors (6) . The following morning, blood was centrifuged at 3000 rpm for 15 min. The supernatant serum was care fully drawn off and passed through a 0.2-pm filter into 2-ml aliquots. The aliquots were frozen at -20°C until needed.
Dissociation of Cells
On attaining confluence, cells were detached from tissue culture flasks with porcine trypsin (Sigma Ltd.).
Cell monolayers were washed four times in calciumand magnesium-free HBSS. One milliliter of 0.05% por cine trypsin in HBSS was added and the flasks were returned to the incubator for 3 min. The flasks were then vigorously shaken to detach any remaining cells and to dissociate the monolayer. Three milliliters of DMEM with 10% FBS was added to stop any further digestion. Acidified ethanol (100 pi) was added to elute the dye and was left for 30 min to allow for homogeneous mix ing of dye and solvent. The absorbance of the plates was read on a spectrophotometer at 540 nm after blanking with acidified ethanol.
Phenotyping of Cultures
In parallel with the proliferation assay, cells of pas sage 2 to 4 were used for phenotyping. They were de 
RESULTS
Early outgrowth from all specimens was obvious by 1 week. Initially cells appeared to migrate across the flask away from the explant. Confluence was usually seen between 28 and 35 days. The cells initially had a stellate appearance, but at greater cell densities devel oped a fibroblastic morphology.
Crystal Violet Assay
There was considerable interindividual variability be tween cancellous bone-derived cell proliferation of dif ferent patients. For example, absorbance by cells treated with 20% AHS ranged from 0.321 to 0.996. However, the overall trend in response to different treatments was the same from patient to patient ( Figs. 1 and 2 AHS, and 10% AHS.
Phenotyping
Cells cultured from all 10 explants were positive for alkaline phosphatase expression and for in vitro mineral ization ( Table 2 ). There was evidence of red staining, positive for calcium deposition and was located in the areas of highest cell density. The deposition was in a trabecular pattern: at higher power, the areas of staining were seen to be made up of many granules of different sizes, frequently approaching the size of neighboring cells.
DISCUSSION
In all 10 patients, cells isolated from bone explants were found to express alkaline phosphatase and to min eralize in vitro, characteristics of human osteoblastic cells (8) . Other authors have also reported a similar inci dence of alkaline phosphatase expression in human bone cell cultures (13) . This is thought to represent the pres ence, within the monolayer, of bone cells at different stages of the cell cycle or differentiation, rather than contaminant cells. While the tests performed on cells in this study are by no means exhaustive, they are sugges tive that these cells are of an osteoblastic lineage. Such phenotyping is important; without it one cannot draw conclusions about "osteoblast" behavior in vitro or ex trapolate to the in vivo milieu. This study has not looked at phenotypic expression of the cells following prolifera tion in AHS, but our previous work has shown that a differentiated phenotype is maintained after human se rum supplementation (10) .
In this study, the answer to two questions was sought. Wergadal and Baylink (24) recommended that the optimal concentration of serum "appeared to be 10% or above," although it should be noted that the maximum concentration used by these authors was 10%. It has been found in the present study that the optimal serum supplementation regimen for human bone cells is 15% or 20%. This is in agreement with the findings of Whitson et al. (25) , who examined the effects of autologous FBS on cells derived from fetal bovine bone and showed that 15% FBS was optimal for proliferation and in vitro mineralization.
Clinical trials of cultured human cancellous bonederived cells have now begun. In a pilot study, five pa- (15) . The experienced gained suggests that 250 ml of serum, harvested at the initial surgical procedure, should be sufficient to support expansion to an estimated population of 100 million cells over a period of 4 months.
In conclusion, this study confirmed that bone-derived cells showed enhanced proliferation, over the studied time period, when supplemented with autologous serum and additionally found that the optimal concentration of serum was above 15%. If this effect is shown to be sus tained in longer term studies, use of autologous serum should be considered at least an important, if not an es sential, prerequisite to cell reimplantation therapy.
